FMAQX | NMAAX | FMAQX / NMAAX | |
Total Expense Ratio | 0.89 | 0.79 | 113% |
Annual Report Gross Expense Ratio | 0.89 | 0.79 | 113% |
Fund Existence | 7 years | 31 years | - |
Gain YTD | -1.973 | -2.111 | 93% |
Front Load | 4% | 4% | 89% |
Min. Initial Investment | 1000 | 2500 | 40% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 333M | 384M | 87% |
Annual Yield % from dividends | 2.88 | 3.34 | 86% |
Returns for 1 year | -0.77 | -0.72 | 107% |
Returns for 3 years | 4.32 | 4.65 | 93% |
Returns for 5 years | -6.78 | -1.99 | 341% |
Returns for 10 years | N/A | 7.68 | - |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
GNOM | 8.40 | 0.05 | +0.58% |
Global X Genomics & Biotechnology ETF | |||
QQQY | 25.99 | 0.09 | +0.35% |
Defiance Nasdaq 100 Target 30 Income ETF | |||
VONV | 84.86 | 0.26 | +0.31% |
Vanguard Russell 1000 Value ETF | |||
IGOV | 42.84 | -0.11 | -0.26% |
iShares International Treasury Bond ETF | |||
UCO | 22.35 | -0.27 | -1.19% |
ProShares Ultra Bloomberg Crude Oil |